FTANX
Price
$13.44
Change
+$0.04 (+0.30%)
Updated
Aug 19 closing price
Net Assets
2.19B
HBLCX
Price
$14.90
Change
+$0.08 (+0.54%)
Updated
Aug 19 closing price
Net Assets
11.12B
Interact to see
Advertisement

FTANX vs HBLCX

FTANX vs HBLCX Comparison Chart in %
View a ticker or compare two or three
VS
FTANX vs. HBLCX commentary
Aug 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTANX is a Hold and HBLCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HBLCX has more cash in the bank: 11.1B vs. FTANX (2.19B). FTANX pays higher dividends than HBLCX: FTANX (2.69) vs HBLCX (2.45). FTANX was incepted earlier than HBLCX: FTANX (19 years) vs HBLCX (20 years). HBLCX (1.65) is less costly to investors than FTANX (0.53). HBLCX is a more actively managed with annual turnover of: 90.00 vs. FTANX (24.00). FTANX has a lower initial minimum investment than HBLCX: FTANX (0) vs HBLCX (2000). HBLCX IRA initial investment is lower compared to FTANX: HBLCX (2000) vs FTANX (500). FTANX annual gain was more profitable for investors over the last year : 10.60 vs. HBLCX (3.75). FTANX return over 5 years is better than : 19.48 vs. HBLCX (1.75).
FTANXHBLCXFTANX / HBLCX
Total Expense Ratio0.501.6530%
Annual Report Gross Expense Ratio0.531.6532%
Fund Existence19 years20 years-
Gain YTD6.1505.301116%
Front LoadN/AN/A-
Min. Initial Investment02000-
Min. Initial Investment IRA500200025%
Net Assets2.19B11.1B20%
Annual Yield % from dividends2.692.45110%
Returns for 1 year10.603.75283%
Returns for 3 years33.2819.44171%
Returns for 5 years19.481.751,115%
Returns for 10 years54.5629.45185%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBTTX44.97N/A
N/A
Fidelity Advisor Biotechnology M
PJFAX64.72N/A
N/A
PGIM Jennison Growth A
MXMSX13.14N/A
N/A
Empower Small Cap Growth Instl
FTMSX35.57N/A
N/A
FullerThaler Behvrl Mcr-Cp Eq Instl
ACMTX12.53N/A
N/A
AB All Market Real Return C